Pancreatic Cancer Research

ResearcherSun Yat-sen University Cancer CenterActive in the last 2 years

Enliang Zhou

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: 1 paper

Papers 3

  1. Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients. First author DOI 10.1007/s00262-025-03948-x↗
  2. Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis. First author DOI 10.1186/s40001-023-01572-y↗
  3. Prognostic nutritional index as a potential prognostic marker for pancreatic cancer after distal pancreatectomy: A single-center, retrospective cohort study Co-author DOI 10.21203/rs.3.rs-2415552/v1↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bokang Cui · 3 shared papers, 2023–2025 · strength 0.74
  2. Xiaohui Li · 2 shared papers, 2023 · strength 0.47
  3. Lingyi Fu · 1 shared paper, 2025 · strength 0.27
  4. Shuo Li · 1 shared paper, 2025 · strength 0.27
  5. Xiaojun Lin · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.